Asston Pharmaceuticals Approves Preferential Allotment of 24.10 Lakh Equity Shares
Asston Pharmaceuticals Ltd 路 Others (Uncategorized) 路 05 Sept 2026, 6:39 pm
Asston Pharmaceuticals Approves Preferential Allotment of 24.10 Lakh Equity Shares On 5th Sep'26, Asston Pharmaceuticals approved the preferential allotment of 24,10,431 equity shares (face value Rs. 10 each) at an issue price of Rs. 115 per share, including a premium of Rs. 105 per share, for cash to 15 public investors. Key allottees include Vijay Rathee (13,17,391 shares) and Vijaylaxmi Infra Projects Private Limited (7,82,608 shares). Post-allotment, the company's paid-up equity share capital expanded to Rs. 10,92,27,910, comprising 1,09,22,791 equity shares. The newly allotted shares rank pari passu with existing equity shares.
Original exchange filing (PDF)
More announcements from Asston Pharmaceuticals Ltd
- Unaudited Financial Results for the Half Year ended 30 September, 2026 with Limited Review Report. 路 12 Nov 2026
- Outcome of the Board Meeting 路 12 Nov 2026
- Asston Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2026 ,inter alia, to consider and approve the Unaudited Financial .... 路 12 Nov 2026
- Change in registered office address 路 13 Oct 2026
- Outcome of the Board held on 13th October, 2026. 路 13 Oct 2026
- Asston Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/10/2026 ,inter alia, to consider and approve matters as attached 路 06 Oct 2026
- Change in Management 路 01 Oct 2026
- Appointment of Statutory Auditor of the Company 路 01 Oct 2026
